Open AccessS302: COST‐EFFECTIVENESS OF KTE‐X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Author(s) -
Marchetti M.,
Visco C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844100.62990.c2
Subject(s) - mantle cell lymphoma , medicine , rituximab , oncology , gemcitabine , refractory (planetary science) , lymphoma , chemotherapy , physics , astrobiology